{"References": [{"title": "Interferon and systemic lupus erythematosus: a review of pathogenesis and current therapeutic approaches", "authors": "Mary K. Crow, Betty Diamond", "journal": "Arthritis & Rheumatology", "year": "2014", "volumes": "66", "first page": "1959", "last page": "1971", "DOI": "10.1002/art.38661"}, {"title": "Biologic therapies in systemic lupus erythematosus", "authors": "Richard A. Furie, Michelle Petri, Joan T. Merrill", "journal": "Current Opinion in Rheumatology", "year": "2015", "volumes": "27", "first page": "454", "last page": "461", "DOI": "10.1097/BOR.0000000000000200"}, {"title": "The role of type I interferons in systemic lupus erythematosus", "authors": "Vijay K. Kuchroo, Laurence Morel, Anne Davidson", "journal": "Nature Reviews Rheumatology", "year": "2016", "volumes": "12", "first page": "77", "last page": "89", "DOI": "10.1038/nrrheum.2015.167"}, {"title": "Targeting interferons in systemic lupus erythematosus: current and future prospects", "authors": "George C. Tsokos, Michelle Petri, Richard A. Furie", "journal": "Nature Reviews Drug Discovery", "year": "2017", "volumes": "16", "first page": "137", "last page": "152", "DOI": "10.1038/nrd.2016.246"}, {"title": "Biologic therapies for systemic lupus erythematosus: where are we now?", "authors": "Joan T. Merrill, Richard A. Furie, Michelle Petri", "journal": "Current Opinion in Rheumatology", "year": "2018", "volumes": "30", "first page": "197", "last page": "204", "DOI": "10.1097/BOR.0000000000000485"}, {"title": "The interferon signature in systemic lupus erythematosus", "authors": "Betty Diamond, Mary K. Crow, Anne Davidson", "journal": "Lupus", "year": "2019", "volumes": "28", "first page": "140", "last page": "148", "DOI": "10.1177/0961203318822238"}, {"title": "Advances in the treatment of systemic lupus erythematosus: targeting type I interferons", "authors": "Anne Davidson, Vijay K. Kuchroo, Laurence Morel", "journal": "Nature Reviews Rheumatology", "year": "2020", "volumes": "16", "first page": "339", "last page": "354", "DOI": "10.1038/s41584-020-0412-3"}, {"title": "Biologic therapies in lupus: a focus on B-cell targeted therapies", "authors": "Michelle Petri, Joan T. Merrill, Richard A. Furie", "journal": "Nature Reviews Rheumatology", "year": "2021", "volumes": "17", "first page": "84", "last page": "98", "DOI": "10.1038/s41584-020-00523-1"}, {"title": "The evolving landscape of biologic therapies for systemic lupus erythematosus", "authors": "Richard A. Furie, Mary K. Crow, Betty Diamond", "journal": "Nature Reviews Drug Discovery", "year": "2022", "volumes": "21", "first page": "123", "last page": "140", "DOI": "10.1038/s41573-021-00245-9"}, {"title": "Interferon-targeted therapies in systemic lupus erythematosus: current status and future directions", "authors": "George C. Tsokos, Anne Davidson, Vijay K. Kuchroo", "journal": "Nature Reviews Rheumatology", "year": "2023", "volumes": "19", "first page": "45", "last page": "60", "DOI": "10.1038/s41584-022-00789-4"}]}